Lilly kicks lobbying into high gear
Once again, Indianapolis-based Eli Lilly and Co. is running in the lead pack in dollars spent to bend ears on Capitol Hill. And that was even before the health care reform debate got rolling.
Health Care & Life Sciences
Articles
Minority suppliers diversifying into life sciences
The Indiana Minority Supplier Development Council has made life sciences companies its latest target—part of an even larger effort to attract minorities to the burgeoning life sciences industry under
way on a national scale.
If Dow AgroSciences sells, let’s hope it’s not to a rival
Private equity firms have a reputation as ruthless acquirers. They slash fat and jettison sluggish product lines, all in a quest to wring out higher profits and grow the parts of the business with the most potential. For Indianapolis-based Dow AgroSciences—or at least for its 1,200 local employees—a buyer like that would be a godsend. […]
Peterson has passion for health care and new Lilly position
A new communications post at Eli Lilly gives former mayor Bart Peterson an opportunity to meld his experiences in the public
and private sectors.
Profs trying to revolutionize drug discovery process
Two chemistry professors at IUPUI are laboring to create the McDonald’s of research laboratories—a model that’s low-cost
and can spread around the world.
With Byetta’s sales stalled, Lilly unveils its own competitor
While Eli Lilly and Co. continues to work with a biotech firm on the diabetes medicine Byetta, it’s developing a potential
competitor to Byetta all on its own.
Wishard Foundation seeks new leader after CEO resigns
The CEO of the Wishard Foundation resigned last month, prompting the fund-raising arm of Wishard Health Services to tap consulting
firm Johnson Grossnickle & Associates for a replacement.
Biotechnology firm boosts its protein biz
Greenwood-based Elona Biotechnologies said it has created two subsidiaries to boost its biosimilar/biogeneric/follow-on protein
business.
Express Scripts closer to $4.7B WellPoint deal
Express Scripts Inc. has cleared an
antitrust review for its planned purchase of Indianapolis-based WellPoint
Inc.’s pharmacy benefits management business, bringing the $4.7 billion deal
closer to completion.
Commercializing science takes too long, Cook says
Taking science from the laboratory to the commercial market takes too much time and is littered with potential pitfalls along the way.
Simple invention targets blanket problem for surgical patients
In a state steeped in advanced research that spawns biomedical companies by the dozen, Apricity LLC is preposterously low-tech,
given that its latest product is nothing more than a warm blanket.
Binford medical complex takes another punch
The anchor tenant in the Binford Medical-Professional Office Complex at the corner of 65th Street and Binford Boulevard has closed temporarily, citing a lack of other tenants in the high-profile medical building. The shut-down is the latest in a string of setbacks for what was to have been a five-building, $29 million development. The Binford […]
‘Epic’ investment losses hit hospitals
Financial reports trickling in from Indianapolis’ major hospitals show why the city’s health care building boom ground to
a near halt this year. It ran into a wall of investment losses.
Prices salty and getting saltier at Indiana nursing homes
The cost of nursing home care in Indianapolis is rising faster than in the rest of the country, according to an annual survey
of long-term-care costs by Virginia-based Genworth Financial.
Reimbursement changes prompt specialists to join hospital payrolls
Specialist physicians, who have traditionally been fiercely independent, are more and more coming on as employees of hospitals.
Activist shareholder makes case against Conseco’s board
An activist shareholder vying to become a director of Conseco Inc. says the insurance company’s board "completely misjudged"
the risks it faced when it emerged from bankruptcy in 2003 and hasn’t recovered since. Now an independent shareholder advisory firm is siding with him.
In Depth Article Placeholder
Ma quande lingues coalesce, t va semblar un simplificat Angles, quam un skeptic Cambridge amico dit me que Occidental es.
$4.7B WellPoint deal leaves workers in limbo
Investors cheered this morning after WellPoint Inc. agreed to sell its pharmacy management unit to Express Scripts Inc., but
the fate of about 2,100 WellPoint employees now is up in the air.
WellPoint to sell subsidiary for $4.6B
WellPoint Inc. has
agreed to sell its pharmacy benefits management arm for $4.675 billion in cash and stock to St. Louis-based Express Scripts,
the companies announced April 13.
Executives make many trips to Washington to argue for 14 years of sales exclusivity for new drugs made from cells
Eli Lilly & Co. executives are making many trips to Washington to argue for 14 years of sales exclusivity for new drugs made
from cells.